SCHEMBL1378899

SCHEMBL1378899

CCOc1nccc(C(Cc2cccc(C#N)c2)(c2cccnc2)c2cccnc2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 1/20 0.39
ALDH1A1 P00352 4/20 0.39
CYP1A2 P05177 3/20 0.39
CYP3A4 P08684 3/20 0.39
CYP2C19 P33261 3/20 0.39
HSD17B10 Q99714 3/20 0.39
CLK4 Q9HAZ1 3/20 0.39
MAPK1 P28482 3/20 0.39
ALOX15 P16050 2/20 0.39
TSHR P16473 1/20 0.39
SGMS2 Q8NHU3 2/20 0.37
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
VNN1 O95497 2/20 0.35
CYP19A1 P11511 2/20 0.34
CYP11B1 P15538 2/20 0.34
CYP11B2 P19099 2/20 0.34
MAPK14 Q16539 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3810699 0.84 ALDH1A1 (0.41) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL3814534 0.83 CYP3A4 (0.40) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL3819160 0.82 CYP3A4 (0.39) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL3814300 0.81 CHRNB2 (0.39) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL1378654 0.79 CYP3A4 (0.39) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL1380977 0.76 CYP3A4 (0.41) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL1379190 0.74 CYP3A4 (0.39) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL1378285 0.72 CYP3A4 (0.41) ALDH1A1CYP1A2CYP3A4CYP2C19CYP19A1
SCHEMBL4184873 0.71 CYP3A4 (0.44) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10
SCHEMBL1378037 0.71 SGMS2 (0.40) ALDH1A1CYP1A2CYP3A4CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4719744-B2 2011-07-06 JP claimed
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP claimed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP claimed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO claimed
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP disclosed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP disclosed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO disclosed